Reported Reactions

Devices › Device types

FDA product code GXY · class 2 · Neurology

Electrode, cutaneous: medical device reports filed with FDA

530 reports carry this product code, 1995–2026; 2 brands with a page.

530
reports with this product code
0% of all MAUDE reports
74
reports, 12 months to August 2026
53 in the 12 months before
42.5%
classified as malfunction
62.3% across all reports
0.2%
classified as death, as reported
0.9% across all reports

Product code GXY is FDA's classification for "Electrode, cutaneous" (neurology panel), a class 2 device. 530 medical device reports carry this product code, 0% of the MAUDE database, from January 1995 to August 2026.

74 reports arrived in the 12 months to August 2026, up 40% from 53 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (42.5%), injury (41.7%) and other (13.6%). 2 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Bis1461130.5%95.2%
Zimmer102.8%17.2%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Ebi438.1%
Conmed275.1%
Mmj De Cv Usd71.3%
Covidien Formerly Tyco Healthcare20.4%
Natus Medical20.4%
Nuvasive20.4%
St Jude Medical - Neuromodulation20.4%
Covidien Juarez Mmj10.2%
Horizon Medical Products10.2%
Medtronic Xomed10.2%
Respironics10.2%

Reports by month, five years

0612Sep 2021: 2Oct 2021: 2Nov 2021: 3Dec 2021: 22022Jan 2022: 1Feb 2022: 3Mar 2022: 4Apr 2022: 2May 2022: 4Jun 2022: 1Jul 2022: 1Aug 2022: 9Sep 2022: 1Oct 2022: 2Nov 2022: 3Dec 2022: 32023Jan 2023: 1Feb 2023: 3Mar 2023: 0Apr 2023: 4May 2023: 3Jun 2023: 1Jul 2023: 1Aug 2023: 2Sep 2023: 2Oct 2023: 1Nov 2023: 4Dec 2023: 32024Jan 2024: 5Feb 2024: 5Mar 2024: 1Apr 2024: 5May 2024: 5Jun 2024: 1Jul 2024: 6Aug 2024: 3Sep 2024: 2Oct 2024: 8Nov 2024: 4Dec 2024: 52025Jan 2025: 5Feb 2025: 4Mar 2025: 8Apr 2025: 6May 2025: 2Jun 2025: 4Jul 2025: 3Aug 2025: 2Sep 2025: 8Oct 2025: 9Nov 2025: 5Dec 2025: 32026Jan 2026: 6Feb 2026: 3Mar 2026: 10Apr 2026: 3May 2026: 5Jun 2026: 12Jul 2026: 8Aug 2026: 2

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0.2%1
Injury41.7%221
Malfunction42.5%225
Other13.6%72
Not given2.1%11

Who filed

Manufacturer report81.7%433
Voluntary report9.6%51
User facility report0%0
Distributor report0.8%4
Not given7.9%42

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Patient device interaction problem5911.1%
Insufficient device problem information5310%
Patient-device incompatibilitythe device did not suit the patient489.1%
High readingsreadings were too high275.1%
Low readingsreadings were too low264.9%
Incorrect measurementthe device measured wrongly244.5%
Unable to obtain readings193.6%
Device operates differently than expectedthe device behaved unexpectedly152.8%
Communication or transmission problemthe device could not communicate or transmit112.1%
Device-device incompatibility112.1%
Improper or incorrect procedure or method112.1%
Reactiona reaction, type not specified112.1%
Material separation81.5%
Image display error/artifact71.3%
Smoking71.3%
Temperature problem71.3%
Incorrect, inadequate or imprecise result or readings61.1%
Other (for use when an appropriate device code cannot be identified)50.9%
Breakthe device broke40.8%
Defective component40.8%

Questions about electrode, cutaneous reports

What is product code GXY?

FDA's classification code for "Electrode, cutaneous", class 2, reviewed by the neurology panel. Every device report carries the product code of the device involved.

How many reports carry this code?

530 reports through August 2026, 74 of them in the latest 12 months.

Which brands appear most often?

Bis (146) and Zimmer (1). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.